{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:01:52Z","timestamp":1792710112226,"version":"4.5.0"},"reference-count":16,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,13]]},"DOI":"10.1182\/bloodadvances.2020002783","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T23:50:38Z","timestamp":1601509838000},"page":"4648-4652","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":70,"title":["Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome"],"prefix":"10.1182","volume":"4","author":[{"given":"Adam S.","family":"Kittai","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-1829","authenticated-orcid":false,"given":"David A.","family":"Bond","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem","family":"William","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-0130","authenticated-orcid":false,"given":"Ayman","family":"Saad","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Penza","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Efebera","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-9836","authenticated-orcid":false,"given":"Karilyn","family":"Larkin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-1046","authenticated-orcid":false,"given":"Sarah A.","family":"Wall","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Choe","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithira","family":"Vasu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Brammer","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Shindiapina","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiao","family":"Long","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-2199","authenticated-orcid":false,"given":"Alice","family":"Mims","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-1884","authenticated-orcid":false,"given":"Lynn","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema A.","family":"Bhat","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5748-7874","authenticated-orcid":false,"given":"Kerry A.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Woyach","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"},{"name":"Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Byrd","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"},{"name":"Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4335-2554","authenticated-orcid":false,"given":"Samantha M.","family":"Jaglowski","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"},{"name":"Arthur G. James Comprehensive Cancer Center,"},{"name":"Wexner Medical Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"15","key":"2020093012565830700_B1","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter\u2019s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020093012565830700_B2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.15035","article-title":"A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor","volume":"180","author":"Rogers","year":"2018","journal-title":"Br J Haematol"},{"issue":"26","key":"2020093012565830700_B3","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2020093012565830700_B4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"2020093012565830700_B5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"2020093012565830700_B6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood.2018885863","article-title":"Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy","volume":"134","author":"van Bruggen","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2020093012565830700_B7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"27","key":"2020093012565830700_B8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"suppl 3","key":"2020093012565830700_B9","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1016\/j.bbmt.2019.12.390","article-title":"Intrathecal chemotherapy: an alternative treatment strategy to prolonged corticosteroids for severe CAR T associated neurotoxicity [abstract]","volume":"26","author":"Yucebay","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"2020093012565830700_B10","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2013-06-506741","article-title":"Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study [published correction appears in Blood. 2014;123(21):3364]","volume":"122","author":"Cruz","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2020093012565830700_B11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J Clin Oncol"},{"issue":"26","key":"2020093012565830700_B12","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1200\/JCO.2017.72.8519","article-title":"Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib","volume":"35","author":"Turtle","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"2020093012565830700_B13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood-2015-11-679134","article-title":"Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia","volume":"127","author":"Fraietta","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2020093012565830700_B14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CJI.0000000000000307","article-title":"Antitumor potency of an anti-CD19 chimeric antigen receptor T-cell therapy, lisocabtagene maraleucel in combination with ibrutinib or acalabrutinib","volume":"43","author":"Qin","year":"2020","journal-title":"J Immunother"},{"key":"2020093012565830700_B15","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-115418","article-title":"Prospective clinical trial of anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia shows a high response rate","volume":"132","author":"Gill","year":"2018","journal-title":"Blood"},{"issue":"19","key":"2020093012565830700_B16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood.2019002936","article-title":"Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure","volume":"135","author":"Gauthier","year":"2020","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/19\/4648\/1760082\/advancesadv2020002783.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/19\/4648\/1760082\/advancesadv2020002783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T23:50:45Z","timestamp":1601509845000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/19\/4648\/463985\/Clinical-activity-of-axicabtagene-ciloleucel-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":16,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020002783","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]}}}